1. Introduction
===============

A number of nucleoside analogues have been found to show a broad spectrum of biological effects such as antifungal \[[@B1-molecules-19-05163],[@B2-molecules-19-05163]\], antibacterial \[[@B1-molecules-19-05163],[@B2-molecules-19-05163],[@B3-molecules-19-05163]\], antitumor \[[@B3-molecules-19-05163],[@B4-molecules-19-05163],[@B5-molecules-19-05163]\], antiviral \[[@B3-molecules-19-05163],[@B4-molecules-19-05163],[@B6-molecules-19-05163],[@B7-molecules-19-05163],[@B8-molecules-19-05163],[@B9-molecules-19-05163],[@B10-molecules-19-05163],[@B11-molecules-19-05163],[@B12-molecules-19-05163],[@B13-molecules-19-05163],[@B14-molecules-19-05163]\] anti-inflammatory \[[@B15-molecules-19-05163]\] and analgesic \[[@B15-molecules-19-05163]\] activities. Moreover, 2\'-deoxy-2\'-fluoro-2\'-*C*-methyl nucleoside analogues have showed promising activity against HCV replication \[[@B16-molecules-19-05163]\]. In addition, nucleoside derivatives display inhibition of glucose-6-phosphatase and showed antihyperglycemic effects \[[@B17-molecules-19-05163]\], as well as inhibition of SAH hydrolase \[[@B18-molecules-19-05163]\]. *C*-Nucleosides are a subtype of these compounds that are of great interest owing to their potential biological activity together with their higher stabilities than that of the corresponding *N*-nucleosides. In light of these interesting biological activities and continuation of our research work to explore potent bioactive nitrogen containing molecules \[[@B1-molecules-19-05163],[@B2-molecules-19-05163]\], some aromatic *C*-nucleoside derivatives were prepared and characterized by analytical and spectral methods.

2. Results and Discussion
=========================

2.1. Chemistry
--------------

Condensation of the carbohydrazide derivative **1B** \[[@B19-molecules-19-05163]\] with carbonyl compounds **2a**--**e**, afforded the corresponding carbohydrazone derivatives **3a**--**e** in 88%--100% yields. Their structures were confirmed by IR, ^1^H-NMR, two dimentional ^1^H-NMR (COSY), ^13^C-NMR and mass spectral data. The ^1^H-NMR spectrum (DMSO-*d*~6~) of compound **3c**, for example, showed five singlets around δ 11.94, 11.14, 8.13, 6.83 and 6.74, supporting the presence of NH~(1)~, NH~(2)~ (D~2~O exchangeable), azomethine (CH=N), CH~(pyrrole)~ and CH~(furan)~ protons, respectively. Signals of the sugar protons of these derivatives **3a**--**e** were assigned from the 2D ^1^H-NMR spectrum of compound **3c**, and the characteristic chemical shifts as compared with those reported for carbohydrazones \[[@B1-molecules-19-05163]\], whereby, four doublets appearing at δ 5.14, 4.75, 4.60, 4.46 ppm were assigned to 1\'-OH, H-1\', 2\'-OH and 3\'-OH, respectively, and a triplet at δ (4.35) ppm for 4\'-OH. Two multiplets at δ 3.56--3.50 and 3.42--3.40 ppm were assigned for H-2\' overlapped with H-3\' and H-4\'a, and the other multiplet for H-4\'b. A broad singlet at δ 2.47 ppm corresponded to the acetyl protons (COC[H~3~]{.ul}), followed by two singlets at δ 2.43 and 2.28 ppm due to methyl protons at the position-2 of the furan ring and C[H~3~]{.ul}~(pyrrole)~, respectively (see Experimental Section and [Scheme 1](#molecules-19-05163-f010){ref-type="scheme"}).

Periodate oxidation of **3e** afforded the corresponding 5-formyl derivative **4**, whose infrared spectrum showed the aldehyde carbonyl functional group at γ 1,689 cm^−1^. In addition the ^1^H-NMR spectrum (DMSO-*d*~6~) of this product, showed a high field singlet at δ 9.60 ppm for the aldehyde proton (C[H]{.ul}O). The mass spectrum showed the molecular ion peak at *m/z* 297 (M^+^, 22.54%).

Acetylation of compounds **3b** and **3e**, afforded the corresponding acetyl derivatives **5** and **6**, in 95% and 100% yield, respectively, as indicated by their spectral data. Oxidative cycization \[[@B1-molecules-19-05163],[@B2-molecules-19-05163],[@B20-molecules-19-05163]\] of the carbohydrazone **5**, gave the 1,3,4-oxadiazole derivative **7** which lacked the carbonyl and NH bands in its infrared spectrum. The mass spectrum gave the parent ion peak at *m/z* 559 (M^+^, 18.83%). (see Experimental Section and [Scheme 2](#molecules-19-05163-f011){ref-type="scheme"}).

On the other hand, boiling of the tetrayltetraacetate **7** with hydrazine hydrate resulted in the corresponding tetrahydroxybutyl derivative **8** in 97% yield. Its IR spectrum showed the hydroxyl groups (OH) at γ 3387--3200 cm^−1^, while the corresponding ^1^H-NMR spectrum revealed the four hydroxyl protons at δ 5.23--4.37 ppm, and the mass spectrum showed the molecular ion peak in agreement with expected molecular weight of compound **8**. Moreover, dehydrative cyclization of the tetraol derivative **8** with aqueous acetic acid (10%) afforded the aromatic *C*-nucleoside **9** in 63% yield, as detected from its spectral data. Its ^1^H-NMR spectrum (DMSO-*d*~6~) showed only two D~2~O-exchangeable hydroxyl protons for 2\'-OH and 3\'-OH, as two doublets at δ 5.16 and 5.03 ppm, respectively. The mass spectrum showed the expected molecular ion peak in agreement with its structure.

![Synthesis of carbohydrazones **3a**--**e** and **4**.](molecules-19-05163-g010){#molecules-19-05163-f010}

![Synthesis of aromatic *C*-nucleosides **5**--**9**.](molecules-19-05163-g011){#molecules-19-05163-f011}

Condensative cyclization of carbohydrazone **3a** with acetic anhydride in the presence of anhydrous sodium acetate gave a cyclized product that according to physical and chemical studies, could not be reconciled with the structure of **10a**, that but rather was compatible with that of \[1,3,4\]oxadiazolo-\[2,3-a\]isoindole **10b**. The infrared spectrum of this compound showed the disappearance of the carboxylic acid hydroxyl group, sugar hydroxyl groups, and CONH absorption bands. It showed instead an acetoxyl (OAc) group at γ 1,744 cm^−1^ and carbonyl groups at γ 1,725 and 1,712 cm^−1^. Its ^1^H-NMR spectrum (CDCl~3~) showed the disappearance of signals corresponding to the sugar protons at the δ 3.00--5.00 ppm region, and only displayed the aromatic protons as a doublet at δ 7.84 (*J* = 7.65 Hz) for Ar-H~(a)~, a triplet at δ 7.65 (*J* = 7.65 Hz) for Ar-H~(b)~, a triplet at δ 7.56 (*J* = 7.65 Hz) for Ar-H~(c)~, and a doublet at δ 7.53 (*J* = 7.65 Hz) for Ar-H~(d)~, followed by a singlet attributed to CH~(furan)~ at δ 7.00 ppm. Three singlet signals that appeared in the upper field region at δ 2.56, 2.27 and 2.14 ppm were attributed to the C[H~3~]{.ul}~(furan)~, COC[H~3~]{.ul} and *O*-acetyl protons, respectively. It is noteworthy that the integration of the OAc protons (δ 2.14 ppm), indicated only one *O*-acetyl group, in accord with structure **10b**. Moreover, the proposed mechanism for formation of **10b** may proceed as illustrated in [Scheme 3](#molecules-19-05163-f012){ref-type="scheme"} and [Scheme 4](#molecules-19-05163-f013){ref-type="scheme"}.

In addition, condensation of anhydro derivative **11** \[[@B2-molecules-19-05163]\] with *p*-nitrobenzaldehyde, indoline-2,3-dione (isatin) and [d]{.smallcaps}-galactose in acidic medium afforded the corresponding aromatic *C*-nucleosides **12**--**14**, respectively. Compounds **12** and **13** were also obtained by acid-catalyzed dehydrative cyclization of **3b** and **3e**, respectively. Their structures were deduced from the respective spectral data. The signals of the sugar protons of anhydro structures **12** and **13** were assigned from the characteristic chemical shifts as compared with those reported for diol derivatives \[[@B2-molecules-19-05163]\]. Although the coupling constant value (*J*~1\',2\'~ = 6.85 Hz) of **12** cannot define the anomeric configuration \[[@B21-molecules-19-05163]\], however, it could be β- in accordance with the configuration its precursor \[[@B2-molecules-19-05163]\]. On the other hand, the anomeric configuration of **13** can be ascertained from the large observed coupling constant value (*J*~1\',2\'~ = 9.00 Hz) which indicates a *trans* arrangement of the base moiety and the 2\'-hydroxyl group, *i.e.*, β-[d]{.smallcaps}-configuration.

Furthermore, acetylation of **12** and **13**, afforded the acetylated structures **15** and **16**, in 79% and 67% yields, respectively. The infrared spectra showed OAc absorption bands at γ 1,753, 1,745 cm^−1^, respectively. The ^1^H-NMR spectra (CDCl~3~) of these products revealed two singlet signals at δ 2.00--2.11 ppm attributed to two *O*-acetyl groups. Their mass spectra showed the expected molecular ion peaks in agreement with their proposed structures.

![Synthesis of \[1,3,4\]oxadiazolo\[2,3-a\]-isoindole **10b**.](molecules-19-05163-g012){#molecules-19-05163-f012}

![Proposed mechanism for formation of \[1,3,4\]oxadiazolo\[2,3-a\]isoindole **10b**.](molecules-19-05163-g013){#molecules-19-05163-f013}

The isopropylidene derivative **17** has been prepared from **13** in yield 88%. Its anomeric configuration was confirmed from the zero coupling constant value (*J*~1\',2\'~ = 0.00 Hz), as a β-[d]{.smallcaps}-configuration \[[@B2-molecules-19-05163],[@B21-molecules-19-05163],[@B22-molecules-19-05163]\]. The mass spectrum showed the expected molecular ion peak in agreement with its structure ([Scheme 5](#molecules-19-05163-f014){ref-type="scheme"}).

The pyrazole derivative **18** was obtained in 100% yield from the reaction of carbohydrazide **1** with pentane-2,4-dione as previously reported on other systems \[[@B23-molecules-19-05163]\]. The infrared spectrum showed the disappearance of absorption bands corresponding to NH and NH~2~. Its ^1^H-NMR spectrum (DMSO-*d*~6~), revealed three singlets at δ 6.18, 2.48 and 2.16 ppm for CH~(pyrazole)~, CH~3(pyrazole-a)~ and CH~3(pyrazole-b)~ protons, respectively. The molecular ion peak recorded in the mass spectrum was in accordance with its molecular weight. Furthermore, the *O*-acetyl derivative **19** was prepared, in which the signals of the sugar protons of this product were assigned from its 2D ^1^H-NMR spectrum ([Scheme 6](#molecules-19-05163-f015){ref-type="scheme"}).

Moreover, condensation of **1** with phenyl isothiocyanate gave the corresponding thiosemicarbazide derivative **20** \[[@B24-molecules-19-05163]\]. Intramolecular cyclization of this thiosemicarbazide using an improved procedure involving treatment with potassium iodide and iodine in the presence of sodium hydroxide \[[@B25-molecules-19-05163]\] resulted in 1,3,4-oxadiazole product **21** \[[@B24-molecules-19-05163]\] in 95% yield. The tetra-*O*-acetyl derivative **22** was obtained in 85% yield, the signals of the sugar protons of this product were assigned from its 2D ^1^H-NMR spectrum, the mass spectrum showed the molecular ion peak at *m/z* 529 (M^+^, 19.12%), and ^13^C-NMR (CDCl~3~) spectrum confirmed the structure ([Scheme 7](#molecules-19-05163-f016){ref-type="scheme"}).

![Synthesis of aromatic *C*-nucleosides **12**--**17**.](molecules-19-05163-g014){#molecules-19-05163-f014}

![Synthesis of pyrazole derivatives **18** and **19**.](molecules-19-05163-g015){#molecules-19-05163-f015}

![Synthesis of 1,3,4-oxadiazoles **21** and **22**.](molecules-19-05163-g016){#molecules-19-05163-f016}

Alternatively, heating the thiosemicarbazide **20** with aqueous sodium hydroxide (10%) \[[@B25-molecules-19-05163]\] gave a product **23**, whose infrared spectrum showed a C=N absorption at γ 1,624 cm^−1^ with the disappearance of the [CO]{.ul}NH absorption. Moreover, acetylation of **23**, gave 5-(5-(1\',2\',3\',4\'-tetraacetoxybutyl)-2-methylfuran-3-yl)-4-phenyl-2*-N*-acetyl-1,2,4-triazole-3(4*H*)-thione (**24**) in 97% yield. The ^1^H-NMR spectrum (CDCl~3~) revealed the disappearance of the NH proton and showed a singlet due to *N*-acetyl protons at δ 2.77 ppm, followed by three singlets at δ 2.01, 1.99, and 1.97 ppm for four *O*-acetyl groups. The mass spectrum showed a molecular ion peak in accordance with its molecular formula ([Scheme 8](#molecules-19-05163-f017){ref-type="scheme"}).

![Synthesis of 4-phenyl-2*H*-1,2,4-triazole-3(4*H*)-thiones **23**--**26**.](molecules-19-05163-g017){#molecules-19-05163-f017}

Dehydration of **23**, afforded 2\',3\'-diol **25** in yield of 80% ([Scheme 8](#molecules-19-05163-f017){ref-type="scheme"}). The anomeric configuration of **25** can be confirmed as β-[d]{.smallcaps}-configuration (*J*~1\',2\'~ = 9.00 Hz). The mass spectrum showed the expected molecular ion peak at *m/z* 359 (M^+^, 20.21%). The characteristic alcohol M-H~2~O peak appeared at *m/z* 341 (20.21), while the M-SH peak was seen at *m/z* 326 (20.21). The loss of a furanose moiety (C~4~H~8~O~3~) from the molecular ion appeared at *m/z* 255 (20.91). Furthermore, periodate oxidation of **23**, afforded the corresponding 2-carbaldehyde derivative **26**.

2.2. Bioactivity Screening of New Synthesized Aromatic C-Nucleosides
--------------------------------------------------------------------

### 2.2.1. Antioxdant Activity Screening (Using the DPPH Assay)

The diphenylpicrylhydrazyl (DPPH) assay method is based on the reduction of the free radical DPPH with an odd electron which gives a maximum absorption at 517 nm. When antioxidants react with DPPH, giving DPPD-H the absorbance decreases due to decolorization with respect to the number of electrons captured. EC~50~ values for each examined compound as well as standard preparations were calculated according to the method Shahwar *et al.* \[[@B26-molecules-19-05163]\]. A lower EC~50~ value is associated with a higher radical scavenging activity. As shown in [Table 1](#molecules-19-05163-t001){ref-type="table"} and [Table 2](#molecules-19-05163-t002){ref-type="table"} and [Figure 1](#molecules-19-05163-f001){ref-type="fig"}, [Figure 2](#molecules-19-05163-f002){ref-type="fig"}, [Figure 3](#molecules-19-05163-f003){ref-type="fig"}, [Figure 4](#molecules-19-05163-f004){ref-type="fig"}, [Figure 5](#molecules-19-05163-f005){ref-type="fig"} and [Figure 6](#molecules-19-05163-f006){ref-type="fig"} the DPPH radical scavenging activities of the prepared compounds **1**, **3c**--**e**, **4**--**6**, **13**, and **16**--**26** in terms of EC~50~ values were the highest in the case of compounds **20**, **3c**, **3d**, **1** and **22** (0.380, 0.418, 0.448, 0.590 and 0.590 mg, respectively) compared to the EC~50~ of vitamin E used as standard (0.705). Meanwhile nearly the same activities were revealed in case of compounds **23** and **26** (0.720 and 0.725 mg), respectively. In addition, moderate activities were shown for compounds **3e**, **4**, **17** and **25** (0.800, 0.800, 0.825 and 0.815 mg), respectively. Lower activities were observed in case of compounds **5**, **6**, **13**, **16**, **18**, **19**, **21** and **24** with EC~50\ values~ equal to 0.960, ˃ 1.000, 0.900, 0.980, ˃ 1.000, 0.930, ˃ 1.000, ˃ 1.000 mg, respectively, compared to the standard, see [Table 2](#molecules-19-05163-t002){ref-type="table"}.

molecules-19-05163-t001_Table 1

###### 

Absorbance and free radical scavenging activities of tested compounds.

  Conc.(mg/ mL)        Compound 1         Compound 3c       Compound 3d        Compound 3e                                                                
  -------------------- ------------------ ----------------- ------------------ ----------------- ------------------ ------------------ ------------------ -------
  0.150                0.000              0.00              0.000              0.00              0.000              0.00               0.000              0.00
  0.300                0.369              42.61             0.420              47.58             0.337              47.58              0.420              34.68
  0.450                0.330              48.67             0.399              50.69             0.317              50.69              0.399              39.50
  0.600                0.312              51.47             0.380              55.98             0.283              55.98              0.380              42.61
  0.750                0.297              53.81             0.369              57.54             0.273              57.54              0.369              47.58
  0.900                0.273              57.54             0.330              59.40             0.261              59.40              0.330              52.56
  1.000                0.232              63.91             0.297              60.03             0.257              60.03              0.297              57.54
  **Conc. (mg/ mL)**   **Compound 4**     **Compound 5**    **Compound 6**     **Compound 13**                                                            
  **Absorbance**       **% Scavenging**   **Absorbance**    **% Scavenging**   **Absorbance**    **% Scavenging**   **Absorbance**     **% Scavenging**   
  0.150                0.000              0.00              0.000              0.00              0.000              0.00               0.000              0.00
  0.300                0.420              34.68             0.451              29.86             0.511              20.52              0.451              29.86
  0.450                0.389              39.50             0.411              36.08             0.493              23.32              0.420              34.68
  0.600                0.369              42.61             0.389              39.50             0.469              27.06              0.389              39.50
  0.750                0.337              47.58             0.360              44.01             0.440              31.57              0.352              45.25
  0.900                0.305              52.56             0.337              47.58             0.403              37.32              0.337              47.58
  1.000                0.273              57.54             0.317              50.69             0.376              41.52              0.297              53.81
  **Conc. (mg/ mL)**   **Compound 16**    **Compound 17**   **Compound 18**    **Compound 19**                                                            
  **Absorbance**       **% Scavenging**   **Absorbance**    **% Scavenging**   **Absorbance**    **% Scavenging**   **% Scavenging**   **Absorbance**     
  0.150                0.000              0.00              0.000              0.00              0.000              0.00               0.000              0.00
  0.300                0.440              31.57             0.433              32.65             0.451              29.86              0.469              27.06
  0.450                0.413              35.76             0.391              39.19             0.440              31.57              0.420              34.68
  0.600                0.387              39.81             0.370              42.45             0.433              32.65              0.391              39.19
  0.750                0.369              42.61             0.330              48.67             0.420              34.68              0.369              42.61
  0.900                0.341              46.96             0.317              50.69             0.403              37.32              0.337              47.58
  1.000                0.312              51.47             0.303              52.87             0.370              42.45              0.312              51.47
  **Conc. (mg/ mL)**   **Vitamin E**      **Compound 20**   **Compound 21**    **Compound 22**                                                            
  **Absorbance**       **% Scavenging**   **Absorbance**    **% Scavenging**   **Absorbance**    **% Scavenging**   **% Scavenging**   **Absorbance**     
  0.150                0.756              21.25             0.000              0.00              0.000              0.00               0.000              0.00
  0.300                0.712              25.83             0.335              47.90             0.540              16.01              0.391              39.19
  0.450                0.684              28.75             0.305              52.56             0.511              20.52              0.337              47.58
  0.600                0.615              35.93             0.285              55.67             0.483              24.88              0.297              53.81
  0.750                0.420              56.25             0.276              57.07             0.450              30.01              0.283              55.98
  0.900                0.202              78.95             0.252              60.80             0.420              34.68              0.273              57.54
  1.000                0.037              96.14             0.240              62.67             0.391              39.19              0.257              60.03
  **Conc. (mg/ mL)**   **Compound 23**    **Compound 24**   **Compound 25**    **Compound 26**                                                            
  **absorbance**       **% scavenging**   **absorbance**    **% scavenging**   **absorbance**    **% scavenging**   **absorbance**     **% scavenging**   
  0.150                0.000              0.00              0.000              0.00              0.000              0.00               0.000              0.00
  0.300                0.463              27.99             0.511              20.52             0.378              41.21              0.369              42.61
  0.450                0.387              39.81             0.467              27.37             0.346              46.18              0.341              46.96
  0.600                0.322              49.92             0.438              31.88             0.340              47.12              0.326              49.30
  0.750                0.310              51.78             0.418              34.99             0.325              49.45              0.314              51.16
  0.900                0.302              53.03             0.376              41.52             0.316              50.85              0.305              52.56
  1.000                0.292              54.58             0.356              44.63             0.306              52.41              0.299              53.49

molecules-19-05163-t002_Table 2

###### 

EC~50~ values of the prepared compounds **1**, **3c**--**3e**, **4**--**6**, **13**, **16**--**26**.

  Cpd no.                              EC~50~ (mg)   Cpd no.   EC~50~ (mg)
  ------------------------------------ ------------- --------- -------------
  **Vitamin E**                        0.705         **17**    0.825
  **1** \[[@B1-molecules-19-05163]\]   0.590         **18**    ˃1.000
  **3c**                               0.418         **19**    0.930
  **3d**                               0.448         **20**    0.380
  **3e**                               0.800         **21**    ˃1.000
  **4**                                0.800         **22**    0.590
  **5**                                0.960         **23**    0.720
  **6**                                ˃1.000        **24**    ˃1.000
  **13**                               0.900         **25**    0.815
  **16**                               0.980         **26**    0.725

![Free radical scavenging activity of vitamin E.](molecules-19-05163-g001){#molecules-19-05163-f001}

![Free radical scavenging activity of compounds **1**, **3c**--**e**.](molecules-19-05163-g002){#molecules-19-05163-f002}

![Free radical scavenging activity of compounds **4**--**6**, **13**.](molecules-19-05163-g003){#molecules-19-05163-f003}

![Free radical scavenging activity of compounds **16**--**19**.](molecules-19-05163-g004){#molecules-19-05163-f004}

![Free radical scavenging activity of compounds **20**--**22**.](molecules-19-05163-g005){#molecules-19-05163-f005}

![Free radical scavenging activity of compounds **23**--**26**.](molecules-19-05163-g006){#molecules-19-05163-f006}

The obtained data revealed a potential antioxidant activity of all examined compounds but with different EC~50~ values compared to the standard, especially compound **20** which has a distinct thiourea group. In addition, compounds **3c** and **3d** revealed higher antioxidant activities as compared to the standard due to the acidic protons in the pyrrole and indole, respectively, that can be easily oxidized.

### 2.2.2. Anticancer Activity Screening (Cytotoxicity Against Three Cancer Cell Lines)

Different concentrations (50--1.56 µg/mL) of the examined compound **1** were used to screen their cytotoxicity against Human Breast Adrenocarcinoma Cells (MCF-7), Human Colon Carcinoma Cells (HCT) and Human Hepatocellular Liver Carcinoma Cells (HepG-2). Cytotoxic effects of these compounds on the cell viability of the cancer cell lines were observed, as shown in [Table 3](#molecules-19-05163-t003){ref-type="table"} and [Table 4](#molecules-19-05163-t004){ref-type="table"} and [Figure 7](#molecules-19-05163-f007){ref-type="fig"}, [Figure 8](#molecules-19-05163-f008){ref-type="fig"} and [Figure 9](#molecules-19-05163-f009){ref-type="fig"}. The obtained data revealed that the carbohydrazide **1** has excellent cell growth inhibitory effects on HepG-2, HCT and MCF-7 with IC~50~s equal to 10.200, 8.400 and 11.700 µg, respectively compared to the IC~50~ of the doxorubicin (1.200, 0.469) and vinblastine (6.100) standards used, see [Table 5](#molecules-19-05163-t005){ref-type="table"}.

molecules-19-05163-t003_Table 3

###### 

Effect of standard compounds on cell viability using cytotoxic assay.

  Conc. (μg/mL)   Doxorubicin for HCT   Doxorubicin for HepG-2   Vinblastine for MCF-7
  --------------- --------------------- ------------------------ -----------------------
  50.000          6.82                  10.95                    7.82
  25.000          8.89                  14.29                    15.18
  12.500          14.83                 16.90                    29.6
  6.250           16.16                 21.03                    48.75
  3.125           22.28                 30.32                    60.35
  1.560           34.64                 48.25                    76.24
  0.780           45.78                 57.44                    ....
  0.390           51.08                 ....                     ....
  0.000           100.00                100.00                   100.00

molecules-19-05163-t004_Table 4

###### 

Effect of different concentrations of compound **1** on cell viability using cytotoxic assay.

  Conc. (μg/mL)   Viability % for HCT   Viability % for HepG-2   Viability % for MCF-7
  --------------- --------------------- ------------------------ -----------------------
  50.000          10.68                 11.56                    14.68
  25.000          19.09                 26.34                    30.49
  12.500          27.25                 39.18                    47.84
  6.250           61.87                 68.47                    64.98
  3.125           83.08                 89.05                    79.82
  1.560           94.62                 93.78                    90.18
  0.000           100.00                100.00                   100.00

![Viability activity against HepG-2 of compound **1**.](molecules-19-05163-g007){#molecules-19-05163-f007}

![Viability activity against HCT-116 of compound **1**.](molecules-19-05163-g008){#molecules-19-05163-f008}

![Viability activity against MCF-7 of compound **1**.](molecules-19-05163-g009){#molecules-19-05163-f009}

molecules-19-05163-t005_Table 5

###### 

IC~50~ of compound **1** on cell viability using cytotoxic assay compared to standards.

  Standard   IC~50~ (μg/mL)           
  ---------- ---------------- ------- -------
  Cpd. 1     8.400            10.20   11.70

3. Experimental
===============

3.1.General Procedures
----------------------

Melting points were determined with a Melt-temperature apparatus and are uncorrected. TLC was performed on Baker-Flex silica gel 1B-F plates and the spots were detected by UV light absorption. IR spectra were recorded on a Perkin Elmer spectrometer. ^1^H-NMR and ^13^C-NMR were recorded on JEOL JNM ECA 500 MHz and 300 MHz instruments using tetramethylsilane as an internal standard. Mass spectra were recorded on a GCMS DI Analysis Shimadzu Qp-2010 Plus. Solutions were evaporated under diminished pressure unless otherwise stated. ChemDraw-Ultra-8.0 has been used in generating the names of the prepared compounds.

3.2. Chemistry
--------------

### 3.2.1. 5-(1\',2\',3\',4\'-Tetrahydroxybutyl)-2-methylfuran-3-carbohydrazide (**1**)

Mp 200--201 °C (Lit. \[[@B1-molecules-19-05163]\], 198 °C); IR(KBr) cm^−1^: 3400--3137 (OH, NH), 1674 (C=O); ^1^H-NMR (DMSO-*d*~6~); δ: 2.46 (s, 3H, CH~3(furan)~), 3.34--3.40 (m, 3H, H-4\'b, NH~2~ with H~2~O of DMSO), 3.44--3.58 (m, 3H, H-3\', H-2\', H-4\'a), 4.36 (t, 1H, 4\'-OH, *J*~4\',OH~ = 5.35 Hz, D~2~O-exchangeable), 4.48 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.85 Hz, D~2~O-exchangeable), 4.61 (d, 1H, 2\'-OH, *J*~2\',OH~ = 5.35 Hz, D~2~O-exchangeable), 4.73 (d, 1H, H-1\', *J*~1\',2\'~ = 5.35 Hz), 5.14 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.10 Hz, D~2~O-exchangeable), 6.70 (s, 1H, CH~(furan)~), 9.79 (s, 1H, NH, D~2~O-exchangeable).

### 3.2.2. General Method for the Synthesis of Carbohydrazones **3a**--**e**

A mixture of 3-carbohydrazide **1** (1.923 mmoL) and carbonyl compound (1.923 mmoL) was heated under reflux in ethanol (10 mL) containing a few drops of acetic acid for 1 h. The products **3a**--**e** that separated were filtered off and dried.

*2-((5-(1\',2\',3\',4\'-Tetrahydroxybutyl)-2-methylfuran-3-carboylimino)methyl)benzoic acid* (**3a**). Obtained in 91% yield from carbohydrazide **1** (1.923 mmoL) and 2-formylbenzoic acid (1.923 mmoL); recrystallized from ethanol as white crystals; mp 209--210 °C; Rf: 0.85 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3429--3305 (OH), 3187 (NH), 1703 (CO-acid), 1653 (CO-amide), 1593 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.50 (s, 3H, CH~3(furan)~), 3.46--3.49 (m, 1H, H-4\'b), 3.53--3.59 (m, 3H, H-3\', H-2\', H-4\'a), 4.36 (bs, 1H, 4\'-OH, D~2~O-exchangeable), 4.49 (bs, 1H, 3\'-OH, D~2~O-exchangeable), 4.62 (bs, 1H, 2\'-OH, D~2~O-exchangeable), 4.76 (s, 1H, H-1\'), 5.16 (bs, 1H, 1\'-OH, *J*~1\',OH~ = 6.00 Hz, D~2~O-exchangeable), 6.83 (s, 1H, CH~(furan)~), 7.47 (t, 1H, Ar-H~(d)~, *J* = 7.65 Hz), 7.60 (t, 1H, Ar-H~(c)~, *J* = 7.65 Hz), 7.85 (d, 1H, Ar-H~(b)~, *J* = 7.65 Hz), 8.01 (d, 1H, Ar-H~(a)~, *J* = 7.65 Hz), 9.08 (s, 1H, CH=N), 11.60 (s, 1H, NH, D~2~O-exchangeable), 12.58 (bs, 1H, CO[OH]{.ul}, D~2~O-exchangeable); MS: *m/z* (%), 393 (25.33, M^+^+1), 392 (28.00, M^+^), 357 (25.78), 347 (23.11), 343 (40.00), 330 (32.89), 300 (40.89), 262 (46.67), 251 (52.44), 220 (36.44), 208 (37.33), 183 (46.67), 177 (25.33), 154 (32.44), 151 (32.44), 146 (38.67), 137 (32.89), 102 (33.78), 91 (38.22), 89 (100.00), 77 (43.11), 65 (38.22), 50 (28.00); Anal. Calcd for C~18~H~2~0N~2~O~8~: C, 55.10; H, 5.14; N, 7.14%; found: C, 55.20; H, 5.00; N, 7.23%.

*N-(4-Nitrobenzylidene)-5-(1\',2\',3\',4\'-tetrahydroxybutyl)-2-methylfuran-3-carbohydrazide* (**3b**). Obtained in 98% yield from carbohydrazide **1** (1.923 mmoL) and *p*-nitrobenzaldehyde (1.923 mmoL); recrystallized from ethanol as yellow crystals. Rf: 0.38 (chloroform--methanol, 5:1, *v/v*); mp 163--164 °C; IR (KBr): 3447--3202 (OH, NH), 1664 (C=O), 1585 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.51 (s, 3H, CH~3(furan)~), 3.38--3.42 (m, 1H, H-4\'b), 3.46--3.51 (m, 1H, H-4\'a ), 3.52--3.54 (m, 1H, H-3\'), 3.55--3.60 (m, 1H, H-2\'), 4.36 (t, 1H, 4\'-OH *J*~4\',OH~ = 5.35 Hz, D~2~O exchangeable), 4.49 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.90 Hz, D~2~O exchangeable), 4.61 (d, 1H, 2\'-OH, *J*~2\',OH~ = 5.35 Hz, D~2~O exchangeable), 4.77 (d, 1H, H-1\',*J*~1\',2\'~ = 6.10 Hz), 5.18 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.90 Hz, D~2~O exchangeable), 6.80 (s, 1H, CH~(furan)~), 7.92 (d, 2H, Ar-H~(b)~, *J* = 7.65 Hz), 8.26 (d, 2H, Ar-H~(a)~, *J* = 8.45 Hz), 8.46 (s, 1H, CH=N), 11.67 (s, 1H, NH, D~2~O exchangeable); MS: *m/z* (%), 394 (20.12, M^+^+1), 393 (26.33, M^+^), 375 (16.86), 355 (28.11), 347 (24.85), 307 (28.99), 306 (25.44), 287 (25.74), 271 (16.27), 245 (15.98), 227 (23.08), 221 (28.99), 211 (47.04), 151 (100.00), 143 (20.71), 138 (21.60), 137 (26.63), 123 (52.66), 113 (24.26), 95 (42.31), 94 (42.31), 81 (26.33), 77 (24.26), 76 (19.53), 65 (22.49), 58 (23.96), 53 (37.28); Anal. Calcd for C~17~H~19~N~3~O~8~: C, 51.91; H, 4.87; N, 10.68%; found: C, 51.95; H, 4.81; N, 10.55%.

*N-((4-Acetyl-5-methyl-1H-pyrrol-2-yl)methylene)-5-(1\',2\',3\',4\'-tetrahydroxybutyl)-2-methylfuran-3-carbohydrazide* (**3c**). Obtained in 88% yield from carbohydrazide **1** (1.923 mmoL) and 4-acetyl-5-methyl-1*H*-pyrrole-2-carbaldehyde (1.923 mmoL); recrystallized from ethanol as white crystals; Rf: 0.52 (chloroform--methanol, 5:1, *v/v*); mp 160--161 °C; IR (KBr): 3409 (OH), 3262 (NH-pyrrole), 3222 (NH-amide), 1642 (2C=O), 1619 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.28 (s, 3H, CH~3(pyrrole)~), 2.43 (s, 3H, CH~3(furan)~), 2.47 (bs, 3H, COCH~3~ with DMSO), 3.42--3.40 (m, 1H, H-4\'b), 3.56--3.50 (m, 3H, H-3\', H-2\', H-4\'a), 4.35 (t, 1H, 4\'-OH, *J*~4\'-OH~ = 6.00 Hz, D~2~O-exchangeable), 4.46 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.60 (d, 1H, 2\'-OH, *J*~2\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.75 (d, 1H, H-1\', *J*~1\',2\'~ = 6.00 Hz), 5.14 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.00 Hz, D~2~O-exchangeable), 6.74 (s, 1H, CH~(furan)~), 6.83 (s, 1H, CH~(pyrrole)~), 8.13 (s, 1H, CH=N), 11.14 (s, 1H, NH~(2)~, D~2~O exchangeable), 11.94 (s, 1H, NH~(1)~, D~2~O exchangeable); ^13^C-NMR (DMSO-*d*~6~); δ: 13.88 (CH~3-pyrrole~ and CH~3-furan~), 28.80 (CO[CH~3~]{.ul}), 63.84, 66.56, 71.54 and 73.25 for (C-4\', C-3\', C-2\' and C-1\'), 105.90, 115.35, 115.80, 122.17, 125.93, 139, 139.5, 155.10 and 155.89 for (pyrrole and furan carbons and CH=N), 159.86 ([CO]{.ul}-NH), 193.86 ([CO]{.ul}CH~3~); MS: *m/z* (%), 395 (53.39, M^+^+2), 394 (69.49, M^+^+1), 393 (44.07, M^+^), 361 (57.63), 359 (71.19), 358 (55.93), 357 (59.32), 344 (62.71), 340 (55.93), 323 (64.41), 311 (60.17), 259 (59.32), 254 (57.63), 242 (79.66), 233 (53.39), 228 (72.88), 223 (66.95), 206 (55.08), 195 (71.19), 191 (64.41), 185 (60.17), 180 (64.41), 158 (59.32), 148 (66.10), 123 (66.95), 116 (64.41), 108 (55.93), 106 (68.64), 91 (100.00), 75 (55.93), 63 (60.17); Anal. Calcd for C~18~H~23~N~3~O~7~: C, 54.96; H, 5.89; N, 10.68%; found: C, 54.91; H, 5.77; N, 10.56%.

*N-((4,5,6,7-Tetrahydro-6,6-dimethyl-4-oxo-1H-indol-2-yl)methylene)-5-(1\',2\',3\',4\'-tetrahydroxybutyl)-2-methylfuran-3-carbohydrazide* (**3d**). Obtained in 90% yield from carbohydrazide **1** (1.923 mmoL) and 4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-1*H*-indole-2-carbaldehyde (1.923 mmoL); recrystallized from ethanol as white crystals; Rf: 0.7 (chloroform--methanol, 4:1, *v/v*); mp 194--195 °C; IR (KBr): 3345 (OH), 3257 (NH- indole), 3158 (NH-amide), 1656 (2C=O), 1618 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 0.99 (s, 6H, 2CH~3(indole)~), 2.20 (s, 2H, CH~2(indole)~), 2.47 (s, 3H, CH~3(furan)~ with DMSO), 2.67 (s, 2H, CH~2(indole)~), 3.38--3.43 (m, 1H, H-4\'b), 3.49--3.56 (m, 3H, H-3\', H-2\', H-4\'a), 4.31 (t, 1H, 4\'-OH, *J*~4\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.43 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.56 (d, 1H, 2\'-OH, *J*~2\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.75 (d, 1H, H-1\', *J*~1\',2\'~ = 6.00 Hz), 5.10 (d, 1H, 1\'-OH, *J*~1\',OH~ = 9.00 Hz, D~2~O-exchangeable), 6.60 (s, 1H, CH~(furan)~), 6.74 (s, 1H, CH~(indole)~), 8.17 (s, 1H, CH=N), 11.15 (s, 1H, NH~(2)~, D~2~O exchangeable), 11.90 (s, 1H, NH~(1)~, D~2~O exchangeable); MS: *m/z* (%), 434 (19.10, M^+^+1), 433 (73.03, M^+^), 432 (73.03), 378 (69.66), 359 (88.76), 348 (76.40), 343 (83.15), 329 (70.79), 301 (70.79), 296 (73.03), 278 (73.03), 276 (70.79), 275 (79.78), 274 (73.03), 255 (94.38), 250 (69.66), 244 (91.01), 215 (70.79), 214 (76.40), 205 (69.66), 199 (74.16), 195 (79.78), 191 (83.15), 189 (69.66), 185 (73.03), 180 (70.79), 175 (83.15), 174 (70.79), 165 (79.78), 152 (67.42), 144 (78.65), 122 (70.79), 116 (70.79), 112 (70.79), 89 (78.65), 75 (61.80), 65 (80.90), 52 (100.00); Anal. Calcd for C~21~H~27~N~3~O~7~: C, 58.19; H, 6.28; N, 9.69%; found: C, 58.14; H, 6.10; N, 9.70%.

*5-(1\',2\',3\',4\'-Tetrahydroxybutyl)-2-methyl-N-(2-oxoindolin-3-ylidene)furan-3-carbohydrazide* (**3e**). Obtained in 100% yield from carbohydrazide **1** (1.923 mmoL) and isatin (1.923 mmoL); recrystallized from ethanol as yellow needles; mp 206--207 °C; Rf: 0.61 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3402 (OH), 3250 (2NH), 1675 (2CO), 1620 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.55 (s, 3H, CH~3(furan)~), 3.39--3.42 (m, 1H, H-4\'b), 3.51--56 (m, 3H, H-3\', H-2\', H-4\'a), 4.32 (t, 1H, 4\'-OH, *J*~4\',OH~ = 3.00 Hz, D~2~O-exchangeable), 4.53 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.58 (d, 1H, 2\'-OH, *J*~2\',OH~ = 3.00 Hz, D~2~O-exchangeable), 4.79 (d, 1H, H-1\', *J*~1\',2\'~ = 6.00 Hz), 5.20 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.00 Hz, D~2~O-exchangeable), 6.52 (s, 1H, CH~(furan)~), 6.93 (d, 1H, Ar-H~(d)~, *J* = 9.00 Hz), 7.07 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.35 (t, 1H, Ar-H~(b)~, *J* = 9.00 Hz), 7.55 (d, 1H, Ar-H~(a)~, *J* = 9.00 Hz), 11.25 (bs, 1H, NH~(2)~, D~2~O-exchangeable), 13.40 (bs, 1H, NH~(1)~, D~2~O-exchangeable); MS: *m/z* (%), 391 (11.64, M^+^+2), 390 (13.87, M^+^+1), 389 (11.13, M^+^), 379 (11.99), 374 (12.16), 333 (11.13), 314 (12.55), 302 (12.50), 283 (12.16), 269 (12.67), 268 (12.50), 263 (15.24), 252 (13.53), 236 (13.87), 229 (12.16), 221 (13.53), 196 (13.36), 194 (13.53), 154 (13.36), 149 (16.27), 137 (17.64), 125 (14.73), 124 (18.15), 123 (13.36), 119 (13.87), 115 (14.73), 113 (13.01), 112 (17.12), 111 (23.46), 110 (12.16), 109 (21.58), 107 (13.01), 103 (11.99), 101 (15.75), 100 (12.67), 99 (12.16), 98 (12.67), 97 (38.01), 96 (29.79), 95 (32.19), 94 (15.75), 85 (29.79), 84 (35.79), 83 (44.86), 82 (22.60), 81 (36.64), 79 (20.89), 73 (20.89), 71 (45.03), 70 (32.53), 69 (82.53), 68 (23.97), 67 (38.70), 66 (13.87), 60 (19.52), 57 (100.00), 56 (37.67), 55 (88.01), 54 (24.32); Anal. Calcd for C~18~H~19~N~3~O~7~: C, 55.53; H, 4.92; N, 10.79%; found: C, 55.42; H, 5.00; N, 10.88%.

### 3.2.3. 5-Formyl-2-methyl-N-(2-oxoindolin-3-ylidene)furan3-carbohydrazide (**4**)

A solution of compound **3e** (3.856 mmol) in distilled water (20 mL) was treated dropwise with a solution of sodium metaperiodate (11.568 mmol) in distilled water (20 mL) under continuous stirring for 3 h, and the formyl derivative that separated out was filtered off, washed with water, and dried. Yield 92%; recrystallized from ethanol as yellow crystals; mp 280 °C; Rf: 0.44 (chloroform--methanol; 30:1; *v/v*); IR (KBr) cm^−1^: 3158 (2NH), 1689 (CHO), 1665 (2CO), 1623 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.67 (s, 3H, CH~3(furan)~), 6.93 (d, 1H, Ar-H~(d)~, *J* = 9.00 Hz), 7.07 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.36 (t, 1H, Ar-H~(b)~, *J* = 9.00 Hz), 7.58 (d, 1H, Ar-H~(a)~, *J* = 9.00 Hz), 7.78 (bs, 1H, CH~(furan)~), 9.60 (s, 1H, CHO), 11.34 (bs, 1H, NH~(2)~, D~2~O exchangeable), 13.48 (bs, 1H, NH~(1)~, D~2~O exchangeable); MS: *m/z* (%), 299 (0.83, M^+^+2), 298 (4.73, M^+^+1), 297 (22.54, M^+^), 269 (7.98), 161 (6.47), 160 (56.39), 159 (11.55), 138 (9.53), 137 (100.00), 136 (6.51), 133 (5.46), 132 (34.79), 104 (19.95), 103 (7.02), 95 (27.88), 90 (5.27), 80 (25.66), 79 (5.02), 78 (6.35), 77 (26.54), 76 (12.05), 64 (26.21), 52 (17.43), 51 (28.02), 50 (13.37); Anal. Calcd for C~15~H~11~N~3~O~4~: C, 60.61; H, 3.73; N, 14.14%; found: C, 60.55; H, 3.78; N, 14.00%.

### 3.2.4. General Method for the Synthesis of the Acetylated Acyclic Aromatic C-Nucleosides **5** and **6**

A solution of 1\',2\',3\',4\'-tetrahydroxybutyl derivatives **3b** and **3e** (2.544 mmoL) in dry pyridine (10 mL) was treated with acetic anhydride (10 mL), and the mixture was kept at room temperature for 5--12 h with occasional shaking. Then it was poured onto crushed ice, the acetyl derivative that separated out, was filtered off, washed with water and dried.

*N-(4-Nitrobenzylidene)-5-(1\',2\',3\',4\'-tetraacetoxybutyl)-2-methylfuran-3-carbohydrazide* (**5**). Obtained in 95% yield from compound **3b** (2.544 mmoL); recrystallized from methanol as yellow crystals; Rf: 0.67 (*n*-hexane--ethyl acetate, 1:1, *v/v*); mp 158--159 °C; IR (KBr): 3286 (NH), 1741 (OAc), 1648 (CO-amide), 1580 (C=N); ^1^H-NMR (CDCl~3~); δ: 1.95, 2.03 and 2.04 (3s, 12H, 4OAc), 2.51 (s, 3H, CH~3(furan)~), 4.08--4.12 (dd, 1H, H-4\'b, *J*~3\',4\'b~ = 5.35 Hz, *J*~4\'b,4\'a~ = 12.20 Hz), 4.18 (d, 1H, H-4\'a, *J*~4\'b,4\'a~ = 11.50 Hz), 5.05--5.06 (m, 1H, H-3\'), 5.44 (bs, 1H, H-2\'), 5.99 (d, 1H, H-1\', *J*~1\',2\'~ = 4.6 Hz), 6.98 (s, 1H, CH~(furan)~), 7.93 (d, 2H, Ar-H~(b)~, *J* = 7.65 Hz), 8.26 (d, 2H, Ar-H~(a)~, *J* = 7.65 Hz), 8.43 (s, 1H, CH=N), 11.69 (s, 1H, NH, D~2~O exchangeable); MS: *m/z* (%), 562 (10.89, M^+^+1), 561 (15.45, M^+^), 546 (16.04), 520 (20.79), 515 (14.46), 489 (10.30), 439 (11.88), 417 (15.64), 397 (11.88), 385 (18.61), 345 (10.89), 324 (11.88), 273 (10.30), 265 (20.99), 252 (10.89), 227 (10.69), 180 (10.69), 109 (17.62), 108 (15.45), 94 (15.64), 81 (46.73), 80 (18.22), 72 (17.62), 69 (100.00), 66 (10.69), 65 (11.49), 57 (54.65), 55 (49.50); Anal. Calcd for C~25~H~27~N~3~O~12~: C, 53.48; H, 4.85; N, 7.48%; found: C, 53.40; H, 4.71; N, 7.50%.

*5-(1\',2\',3\',4\'-Tetraacetoxybutyl)-2-methyl-N-(N\'-acetyl-2-oxoindolin-3-ylidene)furan-3-carbohydrazide* (**6**). Obtained in 100% yield from compound **3e**; recrystallized from ethanol as yellow needles; mp 154--155 °C; Rf: 0.54 (*n*-hexane--ethyl acetate; 5:1; *v/v*); IR (KBr) cm^−1^: 3283 (NH), 1748 (OAc), 1712 (2CO & NAc), 1608 (C=N); ^1^H-NMR (CDCl~3~); δ: 2.03, 2.05, 2.10 (3s, 12H, 4OAc), 2.65 (s, 3H, CH~3(furan)~), 2.73 (s, 3H, N-Ac), 4.10--4.16 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'b,3\'~ = 3.00 Hz), 4.23--4.28 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'a,3\'~ = 3.00 Hz), 5.16--5.21 (m, 1H, H-3\'), 5.60--5.64 (dd, 1H, H-2\', *J*~1\',2\'~ = 3.00 Hz, *J*~2\',3\'~ = 6.00 Hz), 6.08 (d, 1H, H-1\', *J*~1\',2\'~ = 3.00 Hz), 6.70 (s, 1H, CH~(furan)~), 7.27 (t, 1H, Ar-H~(d)~, *J* = 9.00 Hz), 7.42 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.82 (d, 1H, Ar-H~(b)~, *J* = 9.00 Hz), 8.23 (d, 1H, Ar-H~(a)~, *J* = 9.00 Hz), 13.01 (bs, 1H, NH, D~2~O exchangeable); MS: *m/z* (%), 601 (16.75, M^+^+2), 600 (14.35, M^+^+1), 599 (18.90, M^+^),567 (22.73), 562 (22.49), 556 (14.35), 540 (17.70), 525 (22.49), 518 (21.53), 513 (13.88), 511 (21.29), 490 (18.66), 469 (18.66), 454 (17.70), 452 (23.92), 439 (23.21), 403 (20.10), 397 (52.63), 381 (14.83), 353 (26.56), 340 (26.56), 335 (19.38), 302 (27.27), 272 (21.29), 234 (25.84), 202 (30.14), 193 (92.82), 175 (38.52), 166 (21.53), 151 (32.30), 137 (100.00), 124 (26.56), 115 (28.23), 110 (39.23), 95 (33.97), 77 (42.34), 55 (28.47), 53 (15.55); Anal. Calcd for C~28~H~29~N~3~O~12~: C, 56.09; H, 4.88; N, 7.01%; found: C, 56.03; H, 4.92; N, 6.89%.

*1\'-\[(5-Methyl-4-(5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl)furan-2-yl)\]butane-1\',2\',3\',4\'-tetrayl tetraacetate* (**7**). A solution of compound **5** (5.523 mmol) in dry ether (75 mL) was stirred with yellow mercuric oxide (4.80 g), magnesium oxide (0.48 g), and iodine (4.00 g) at room temperature for 48 h under anhydrous conditions. The reaction mixture was filtered off, and the filtrate washed with potassium iodide solution, sodium thiosulphate, and water respectively, and dried over anhydrous sodium sulphate. On evaporation of the dried filtrate, a yellow crystalline mass was obtained. An additional crop was obtained by extracting the inorganic residue with chloroform which upon concentration yielded the same product. Yield (50%); recrystallized from methanol as yellow crystals; Rf: 0.74 (*n*-hexane--ethyl acetate; 2:1; *v/v*); mp 147--148 °C; IR (KBr) cm^−1^: 1750 (OAc), 1635 (C=N); ^1^H-NMR (CDCl~3~); δ: 1.96, 1.97, 2.05, 2.06 (4s, 12H, 4OAc), 2.65 (s, 3H, CH~3(furan)~), 4.11--4.14 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.20 Hz, *J*~4\'b,3\'~ = 5.35 Hz), 4.20--4.23 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 12.20 Hz, *J*~4\'a,3\'~ = 3.05 Hz), 5.08--5.11 (m, 1H, H-3\'), 5.46--5.49 (dd, 1H, H-2\', *J*~1\',2\'~ = 5.35 Hz, *J*~2\',3\'~ = 6.90 Hz), 6.05 (d, 1H, H-1\', *J*~1\',2\'~ = 4.60 Hz), 7.03 (s, 1H, CH~(furan)~), 8.29 (d, 2H, Ar-H~(b)~, *J* = 8.45 Hz), 8.40 (d, 2H, Ar-H~(a)~, *J* = 9.15 Hz); MS: *m/z* (%), 561 (13.74, M^+^+2), 560 (23.92, M^+^+1), 559 (18.83), 549 (19.34), 528 (21.88), 471 (20.10), 462 (20.61), 457 (29.52), 378 (20.87), 368 (19.34), 301 (25.45), 289 (20.10), 270 (24.68), 250 (24.94), 209 (21.88), 185 (21.37), 183 (21.88), 138 (21.37), 119 (21.37), 82 (23.41), 75 (19.85), 64 (23.41), 63 (17.81), 60 (100.00), 55 (23.92), 57 (22.14); Anal. Calcd for C~25~H~25~N~3~O~12~: C, 53.67; H, 4.50; N, 7.51%; found: C, 53.71; H, 4.44; N, 7.44%.

*1\'-\[(5-Methyl-4-(5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl)furan-2-yl)\]butane-1\',2\',3\',4\'-tetraol* (**8**). A solution of compound **7** (0.894 mmoL) was heated with hydrazine hydrate (10 mL) in methanol (10 mL) under reflux for 1 h. The 1\',2\',3\',4\'-tetraol **8** that separated out was filtered off, washed with methanol and dried. Yield 97%; recrystallized from ethanol as pale yellow crystals; mp 147 °C; Rf: 0.62 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3307 (OH), 1646 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.64 (s, 3H, CH~3(furan)~), 3.39--3.43 (m, 1H, H-4\'b), 3.47--3.52 (m, 1H, H-3\'), 3.54--3.56 (m, 1H, H-2\'), 3.57--3.61 (m, 1H, H-4\'a), 4.37 (t, 1H, 4\'-OH, *J*~4\',OH~ = 6.10 Hz, D~2~O-exchangeable), 4.62 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.90 Hz, D~2~O-exchangeable), 4.66 (d, 1H, 2\'-OH, *J*~2\',OH~ = 5.35 Hz, D~2~O-exchangeable), 4.81 (d, 1H, H-1\', *J*~1\',2\'~ = 6.85 Hz), 5.23 (d, 1H, 1\'-OH, *J*~1\',OH~ = 7.65 Hz, D~2~O-exchangeable), 6.73 (s, 1H, CH~(furan)~), 8.27 (d, 2H, Ar-H~(b)~, *J* = 8.40 Hz), 8.39 (d, 2H, Ar-H~(a)~, *J* = 8.40 Hz); MS: *m/z* (%), 393 (28.16, M^+^+2), 392 (30.58, M^+^+1), 391 (37.86, M^+^), 356 (43.20), 307 (48.54), 300 (100.00), 295 (39.81), 284 (49.51), 279 (44.66), 237 (40.78), 236 (41.75), 228 (40.78), 222 (42.23), 154 (57.77), 147 (43.69), 144 (45.63), 139 (30.58), 137 (75.73), 127 (38.35), 120 (39.32), 104 (67.96), 95 (46.12), 90 (49.51), 79 (43.69), 76 (94.17), 75 (61.65), 57 (48.54), 56 (93.69), 50 (60.19); Anal. Calcd for C~17~H~17~N~3~O~8~: C, 52.18; H, 4.38; N, 10.74%; found: C, 52.24; H, 4.17; N, 10.76%.

*Tetrahydro-1\'-\[(5-methyl-4-(5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl)furan-2-yl)\]-furan-2\',3\'-diol* (**9**). A solution of compound **8** (0.767 mmoL) was heated with aqueous acetic acid (150 mL, 10%) under reflux for 8 h After cooling the 2\',3\'-diol **9** that separated out was filtered off, washed with water and dried. Yield 63%; recrystallized from ethanol as a yellow powder; mp 199--200 °C; Rf: 0.88 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3372 (OH), 1637 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.66 (s, 3H, CH~3(furan)~), 3.62--3.64 (dd, 1H, H-4\'b, *J*~4\'b,3\'~ = 2.30 Hz, *J*~4\'b,4\'a~ = 9.15 Hz), 4.02--4.05 (dd, 1H, H-4\'a, *J*~3\',4\'a~ = 4.55 Hz, *J*~4\'b,4\'a~ = 9.20 Hz), 4.10--4.17 (m, 2H, H-3\', H-2\'), 4.54 (d, 1H, H-1\', *J*~1\',2\'~ = 7.60 Hz), 5.03 (d, 1H, 3\'-OH, *J*~3\',OH~ = 3.85 Hz, D~2~O-exchangeable), 5.16 (d, 1H, 2\'-OH, *J*~2\',OH~ = 6.1 Hz, D~2~O-exchangeable), 6.93 (s, 1H, CH~(furan)~), 8.28 (d, 2H, Ar-H~(b)~, *J* = 8.40 Hz), 8.39 (d, 2H, Ar-H~(a)~,*J* = 9.20 Hz); MS: *m/z* (%), 374 (41.04, M^+^+1), 373 (42.54, M^+^), 328 (48.51), 327 (52.99), 284 (64.93), 257 (79.10), 254 (54.48), 247 (56.72), 238 (67.16), 211 (52.99), 208 (50.75), 206 (50.75), 170 (66.42), 165 (54.48), 154 (52.99), 148 (62.69), 127 (72.39), 109 (52.24), 104 (73.13), 103 (58.96), 77 (56.72), 76 (100.00), 75 (58.96), 65 (92.54), 64 (60.45), 56 (62.69), 50 (47.01); Anal. Calcd for C~17~H~15~N~3~O~7~: C, 54.69; H, 4.05; N, 11.26%; found: C, 54.70; H, 4.00; N, 11.21%.

*4-(9b-Acetyl-5,9b-dihydro-5-oxo-\[1,3,4\]oxadiazolo\[2,3-a\]isoindol-2-yl)-5-methylfuran-2-yl acetate* (**10b**). A solution of compound **3a** (0.765 mmoL) was boiled with acetic anhydride (4 mL) in the presence of anhydrous sodium acetate (0.25 g) for 7 h. The acetyl derivative that separated was filtered off and dried. Yield 59%; recrystallized from methanol as colourless crystals; Rf: 0.47 (*n*-hexane-ethyl acetate, 4:1, *v/v*); mp 168--169 °C; IR (KBr) cm^−1^: 1744 (OAc), 1725 (COCH~3~), 1712 (CO-isoindolone), 1618 (C=N); ^1^H-NMR (CDCl~3~); δ: 2.14 (s, 3H, OAc), 2.27 (s, 3H, COCH~3~), 2.56 (s, 3H, CH~3(furan)~), 7.00 (s, 1H, CH~(furan)~), 7.53 (d, 1H, Ar-H~(d)~, *J* = 7.65 Hz), 7.56 (t, 1H, Ar-H~(c)~, *J* = 7.65 Hz), 7.65 (t, 1H, Ar-H~(b)~, *J* = 7.65 Hz), 7.84 (d, 1H, Ar-H~(a)~, *J* = 7.65 Hz); MS: *m/z* (%), 356 (2.50, M^+^+2), 355 (2.33, M^+^+1), 354 (3.54, M^+^), 248 (9.62), 189 (15.92), 188 (31.58), 148 (10.09), 147 (23.86), 146 (100.00), 133 (29.25), 118 (10.27), 105 (24.07), 104 (10.66), 89 (33.82), 77 (24.16), 76 (16.31), 63 (12.12), 60 (9.15), 51 (13.03); Anal. Calcd for C~18~H~14~N~2~O~6~: C, 61.02; H, 3.98; N, 7.91%; found: C, 61.00; H, 4.00; N, 7.99%.

### 3.2.5. General Procedures for the Preparation of the Aromatic C-Nucleosides **12**--**14**

[*Method A*]{.ul}. A solution of compounds **3b** and **3e** (2.544 mmoL) was heated with aqueous acetic acid (150 mL, 10%) under reflux for 5 h. After cooling the 3-carbohydrazones **12**, **13** that separated out were filtered off, washed with water and dried.

[*Method B*]{.ul}. A solution of 5-(2\',3\'-dihydroxytetrahydrofuran-1\'-yl)-2-methylfuran-3-carbohydrazide (**11**) \[[@B4-molecules-19-05163]\] in ethanol containing a few drops of acetic acid was treated with carbonyl compound, and the reaction mixture was refluxed on water bath for 30 min. After cooling the 3-carbohydrazones **12**--**14** that separated out were filtered off, washed with a little ethanol, and dried.

*N-(4-Nitrobenzylidene)-5-(tetrahydro-2\',3\'-dihydroxyfuran-1\'-yl)-2-methylfuran-3-carbohydrazide* (**12**). Obtained in 90% yield from **11** (0.413 mmol) and 4-nitrobenzaldehyde (0.413 mmol); recrystallized from ethanol as yellow needles; mp 239--240 °C; Rf: 0.69 (chloroform--methanol; 5:1; *v/v*); IR(KBr) cm^−1^: 3292--3245 (OH, NH), 1660 (CO-amide), 1614 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.52 (s, 3H, CH~3(furan)~), 3.61--3.63 (dd, 1H, H-4\'b, *J*~3\',4\'b~ = 2.30 Hz, *J*~4\'b,4\'a~ = 9.20 Hz), 4.01--4.04 (dd, 1H, H-4\'a, *J*~3\',4\'a~ = 4.60 Hz, *J*~4\'b,4\'a~ = 9.20 Hz), 4.06--4.11(m, 2H, H-3\', H-2\'), 4.49 (d, 1H, H-1\', *J*~1\',2\'~ = 6.85 Hz), 5.02 (d, 1H, 3\'-OH, *J~2\',OH~* = 3.80 Hz, D~2~O-exchangeable), 5.12 (d, 1H, 2\'-OH, *J~1\',OH~* = 6.10 Hz, D~2~O-exchangeable), 6.88 (s, 1H, CH~(furan)~), 7.93 (d, 2H, Ar-H~(b)~, *J* = 8.45 Hz), 8.26 (d, 2H, Ar-H~(a)~, *J* = 8.45 Hz Hz), 8.44 (s, 1H, CH=N), 11.67 (s, 1H, NH, D~2~O-exchangeable); MS: *m/z* (%), 376 (4.69, M^+^+1), 375 (11.01, M^+^), 317 (7.58), 212 (12.18), 211 (100.00), 153 (7.94), 151 (51.35), 137 (12.55), 123 (16.52), 115 (9.03), 105 (8.30), 95 (11.10), 81 (13.63), 79 (14.53), 77 (4.15), 70 (9.75), 63 (8.03), 61 (12.36), 55 (12.82), 53 (10.29), 52 (11.82); Anal. Calcd for C~17~H~17~N~3~O~7~: C, 54.40; H, 4.57; N, 11.20%; found: C, 54.50; H, 4.60; N, 11.11%.

*5-(Tetrahydro-2\',3\'-dihydroxyfuran-1\'-yl)-2-methyl-N-(2-oxoindolin-3-ylidene)furan-3-carbohydrazide* (**13**). Obtained in 91% yield from **11** (0.413 mmol) and isatin (0.413 mmol); recrystallized from ethanol as yellow needles; mp 263--264 °C; Rf: 0.69 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3420 (OH), 3166 (2NH), 1703 (CO-oxoindoline), 1673 (CO-amide), 1619 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.57 (s, 3H, CH~3(furan)~), 3.62 (d, 2H, H-4\'b, *J*~4\'b,4\'a~ = 9.00 Hz), 4.01--4.06 (dd, 1H, H-4\'a, *J*~3\',4\'a~ = 6.00 Hz, *J*~4\'b,4\'a~ = 9.00 Hz), 4.10 (bs, 2H, H-3\', H-2\'), 4.53 (d, 1H, H-1\', *J*~1\',2\'~ = 9.00 Hz), 4.94 (bs, 1H, 3\'-OH, D~2~O-exchangeable), 5.09 (bs, 1H, 2\'-OH, D~2~O-exchangeable), 6.64 (s, 1H, CH~(furan)~), 6.93 (d, 1H, Ar-H~(d)~, *J* = 9.00 Hz), 7.07 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.35 (t, 1H, Ar-H~(b)~, *J* = 9.00 Hz), 7.55 (d, 1H, Ar-H~(a)~, *J* = 9.00 Hz), 11.25 (bs, 1H, NH~(2)~, D~2~O-exchangeable), 13.35 (bs, 1H, NH~(1)~, D~2~O-exchangeable); MS: *m/z* (%), 372 (33.14, M^+^+1), 371 (44.57, M^+^), 340 (37.14), 335 (37.14), 294 (40.00), 286 (49.14), 276 (40.00), 268 (37.14), 187 (40.57), 167 (44.57), 141 (40.57), 138 (40.00), 135 (49.71), 126 (43.43), 125 (44.57), 94 (100.00), 88 (46.86), 87 (49.71), 85 (46.86), 83 (55.43), 81 (62.86), 80 (77.14), 79 (48.00), 77 (45.14), 73 (66.29), 72 (42.29), 71 (60.00), 69 (85.71), 64 (69.14), 61 (43.43), 60 (65.14), 57 (82.86), 55 (72.57); Anal. Calcd for C~18~H~17~N~3~O~6~: C, 58.22; H, 4.61; N, 11.32%; found: C, 58.15; H, 4.65; N, 11.44%.

*5-(Tetrahydro-2\',3\'-dihydroxyfuran-1\'-yl)-N-2,3,4,5,6-pentahydroxyhexylidene)-2-methylfuran-3-carbohydrazide* (**14**). Obtained in 93% yield from **11** (0.413 mmol) and [d]{.smallcaps}-galactose (0.826 mmol); recrystallized from ethanol as pale yellow syrup; Rf: 0.44 (chloroform--methanol, 1:1, *v/v*); IR (KBr) cm^−1^: 3380--3150 (OH, NH), 1648 (CO), 1612 (C=N); MS: *m/z* (%), 406 (18.88, M^+^+2), 405 (23.08, M^+^+1), 404 (19.93, M^+^), 395 (24.83), 363 (26.57), 362 (25.87), 354 (23.78), 313 (25.52), 305 (24.48), 294 (23.78), 282 (24.48), 262 (28.67), 250 (26.57), 236 (24.48), 235 (28.67), 228 (28.67), 225 (23.78), 219 (28.67), 209 (24.83), 208 (30.07), 205 (25.87), 175 (25.52), 173 (25.52), 158 (24.83), 157 (26.57), 122 (27.62), 107 (28.67), 73 (100.00), 71 (39.16), 61 (40.91), 60 (81.82), 56 (26.57), 52 (26.57).

### 3.2.6. General Procedure for the Acetylation of the Aromatic C-Nucleosides **12** and **13**

A solution of 2\',3\'-dihydroxyfurans **12** and **13** (0.809 mmoL) in dry pyridine (15 mL) was treated with acetic anhydride (15 mL) and the mixture was kept overnight with occasional shaking at room temperature. Then it was poured onto crushed ice, the acetyl derivatives **15** and **16** that separated out were filtered off, washed with water and dried.

*N-(4-Nitrobenzylidene)-5-(tetrahydro-2\',3\'-diacetoxyfuran-1\'-yl)-2-methylfuran-3-carbohydrazide* (**15**). Obtained in 79% yield from **12** (0.809 mmoL); recrystallized from ethanol as yellow crystals; mp 173--174 °C; Rf: 0.61 (*n*-hexane--ethyl acetate; 1:1; *v/v*); IR (KBr) cm^−1^: 3235 (NH), 1753 (OAc), 1654 (CO), 1600 (C=N); ^1^H-NMR (CDCl~3~); δ: 2.00, 2.06 (2s, 6H, 2OAc), 2.52 (s, 3H, CH~3(furan)~), 3.81--3.84 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 10.70 Hz, *J*~4\'b,3\'~ = 2.30 Hz), 4.25--4.29 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 10.70 Hz, *J*~4\'a,3\'~ = 5.35 Hz), 4.88 (d, 1H, H-3\', *J*~2\',3\'~ = 6.10 Hz), 5.34--5.37 (m, 1H, H-2\'), 5.40--5.42 (m, 1H, H-1\'), 6.98 (s, 1H, CH~(furan)~), 7.93 (d, 2H, Ar-H~(b)~, *J* = 6.85 Hz), 8.26 (d, 2H, Ar-H~(a)~, *J* = 7.65 Hz), 8.43 (s, 1H, CH=N), 11.72 (s, 1H, NH, D~2~O exchangeable); MS: *m/z* (%), 460 (12.29, M^+^+1), 459 (16.74, M^+^), 400 (28.39), 380 (24.15), 340 (74.79), 323 (19.49), 296 (25.21), 295 (100.00), 265 (19.92), 260 (15.47), 258 (17.16), 235 (19.92), 193 (26.91), 192 (25.21), 175 (35.17), 151 (44.28), 150 (26.69), 147 (24.58), 138 (25.00), 137 (54.03), 123 (28.39), 115 (79.87), 105 (27.54), 95 (40.89), 91 (26.27), 85 (25.64), 27 (23.31), 76 (23.52), 63 (25.64), 55 (27.54), 52 (28.39); Anal. Calcd for C~21~H~21~N~3~O~9~: C, 54.90; H, 4.61; N, 9.15%; found: C, 54.79; H, 4.69; N, 9.24%.

*5-(Tetrahydro-2\',3\'-diacetoxyfuran-1\'-yl)-2-methyl-N-(N\'-acetyl-2-oxoindolin-3-ylidene)furan-3-carbohydrazide* (**16**). Obtained in 67% yield from **13** (0.809 mmoL); recrystallized from ethanol as yellow crystals; mp 162--163 °C; Rf: 0.51 (*n*-hexane--ethyl acetate; 5:1; *v/v*); IR (KBr) cm^−1^: 3273 (NH), 1745 (OAc), 1708 (3CO), 1603 (C=N); ^1^H-NMR (CDCl~3~); δ: 2.06, 2.11 (2s, 6H, 2OAc), 2.67 (s, 3H, CH~3(furan)~), 2.73 (s, 3H, N-Ac), 3.93--3.98 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'b,3\'~ = 3.00 Hz), 4.36--4.41 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'a,3\'~ = 3.00 Hz), 4.93 (d, 1H, H-3\', *J*~2\',3\'~ = 6.00 Hz), 5.48--5.55 (m, 2H, H-2\', H-1\'), 6.74 (bs, 1H, CH~(furan)~), 7.27 (t, 1H, Ar-H~(d)~, *J* = 9.00 Hz), 7.42 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.82 (d, 1H, Ar-H~(b)~, *J* = 6.00 Hz), 8.23 (d, 1H, Ar-H~(a)~, *J* = 9.00 Hz), 13.03 (bs, 1H, NH, D~2~O exchangeable); MS: *m/z* (%), 499 (5.52, M^+^+2), 498 (7.88, M^+^+1), 496 (4.73, M^+^-1), 434 (8.23), 379 (11.03), 378 (31.35), 296 (21.54), 295 (100.00), 235 (10.16), 193 (13.66), 192 (10.42), 175 (18.83), 151 (13.84), 149 (13.40), 148 (11.30), 147 (14.19), 137 (34.68), 121 (16.20), 115 (40.72), 109 (13.84), 105 (17.86), 104 (17.43), 95 (34.85), 80 (14.89), 79 (15.06), 77 (23.64), 76 (11.56), 55 (13.22), 52 (12.00), 51 (14.36); Anal. Calcd for C~24~H~23~N~3~O~9~: C, 57.95; H, 4.66; N, 8.45%; found: C, 57.88; H, 4.52; N, 8.50%.

*5-(Tetrahydroj-2,2-dimethylfuro\[2\',3\'-d\]\[1,3\]dioxol-1\'-yl)-2-methyl-N-(2-oxoindolin-3-ylid-ene)furan-3-carbohydrazide* (**17**). Compound **13** (0.485 mmol) was treated with FeCl~3~ (0.035 g) in dry acetone (30 mL). The reaction mixture was heated under reflux for 30 min. After cooling it was poured onto cold water, the separated yellow crystals **17** was filtered off and dried. Yield 88%; recrystallized from ethanol as yellow needles; mp 220 °C; Rf: 0.75 (chloroform--methanol; 20:1; *v/v*); IR (KBr) cm^−1^: 3178 (2NH), 1684 (2CO), 1615 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 1.26, 1.39 (2s, 6H, CMe~2~, Δδ = 0.13), 2.54 (s, 3H, CH~3(furan)~), 3.74--3.69 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'b,3\'~ = 3.00 Hz), 3.87 (d, 1H, H-4\'a, *J*~4\'a,4\'b~ = 12.00 Hz), 4.88--4.95 (m, 2H, H-3\', H-2\'), 4.98 (s, 1H, H-1\', *J*~1\',2\'~ = 0 Hz ), 6.63 (bs, 1H, CH~(furan)~), 6.92 (d, 1H, Ar-H~(d)~, *J* = 9.00 Hz), 7.06 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.36 (t, 1H, Ar-H~(b)~, *J* = 6.00 Hz), 7.53 (d, 1H, Ar-H~(a)~, *J* = 9.00 Hz), 11.28 (s, 1H, NH~(2)~, D~2~O exchangeable), 13.35 (bs, 1H, NH~(1)~, D~2~O exchangeable); MS: *m/z* (%), 413 (0.88, M^+^+2), 412 (5.26, M^+^+1), 411 (20.24, M^+^), 383 (9.26), 252 (16.46), 251 (100.00), 160 (24.84), 159 (10.29), 151 (8.40), 137 (23.36), 132 (16.47), 123 (6.97), 121 (12.88), 110 (8.02), 109 (6.21), 105 (6.89), 104 (15.66), 95 (14.58), 80 (10.20), 79 (18.26), 78 (6.11), 77 (22.12), 76 (6.12), 69 (7.01), 65 (6.34), 59 (14.57), 57 (6.78), 55 (12.70), 53 (8.67), 52 (10.78), 51 (11.09); Anal. Calcd for C~21~H~21~N~3~O~6~: C, 61.31; H, 5.14; N, 10.21%; found: C, 61.26; H, 5.19; N, 10.18%.

*(5-(1\',2\',3\',4\'-Tetrahydroxybutyl)-2-methylfuran-3-yl)(3,5-dimethyl-1H-pyrazol-1-yl)-methanone* (**18**). A mixture of 3-carbohydrazide **1** (5 mmoL) and acetylacetone (5 mmoL) was heated under reflux in ethanol (10 mL) containing a few drops of acetic acid for 5 h. After cooling the solid **18** that separated was filtered off and dried. Yield 100%; recrystallized from ethanol as colorless needles; mp 142--143 °C; Rf: 0.55 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3314 (OH), 1689 (CO), 1560 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.16 (s, 3H, CH~3(b-pyrazole)~), 2.48 (s, 6H, CH~3(furan)~ and CH~3(a-pyrazole)~), 3.39--3.43 (m, 1H, H-4\'b), 3.47--3.58 (m, 3H, H-3\', H-2\', H-4\'a), 4.30 (bs, 1H, 4\'-OH, D~2~O-exchangeable), 4.48 (d, 1H, 3\'-OH, *J~3\',OH~* = 6.00 Hz, D~2~O-exchangeable), 4.56 (bs, 1H, 2\'-OH, D~2~O-exchangeable), 4.76 (d, 1H, H-1\', *J*~1\',2\'~ = 6.00 Hz), 5.11 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.00 Hz, D~2~O-exchangeable), 6.18 (s, 1H, CH~(pyrazole)~), 6.90 (s, 1H, CH~(furan)~); MS: *m/z* (%), 325 (0.17, M^+^+1), 324 (0.30, M^+^), 306 (17.49), 234 (9.75), 233 (32.42), 211 (26.86), 210 (75.30), 203 (23.37), 182 (23.85), 151 (6.04), 138 (6.24), 137 (41.72), 123 (6.09), 122 (7.28), 121 (12.20), 110 (13.35), 109 (12.02), 103 (8.55), 97 (100.00), 96 (10.91), 95 (18.16) 81 (11.08), 79 (11.69), 56 (6.59), 55 (9.48), 53 (11.53), 51 (7.48); Anal. Calcd for C~15~H~20~N~2~O~6~: C, 55.55; H, 6.22; N, 8.64%; found: C, 55.56; H, 6.20; N, 8.59%.

*(5-(1\',2\',3\',4\'-Tetraacetoxybutyl)-2-methylfuran-3-yl)(3,5-dimethyl-1H-pyrazol-1-yl)methanone* (**19**). A solution of compound **18** (1.543 mmoL) in dry pyridine (15 mL) was treated with acetic anhydride (15 mL) and the mixture was kept overnight with occasional shaking at room temperature. Then it was poured onto crushed ice and the acetyl derivative **19** that separated out was filtered off, washed with water and dried. Yield 68%; recrystallized from ethanol as colorless needles; mp 101--102 °C; Rf: 0.74 (*n*-hexane--ethyl acetate; 2:1; *v/v*); IR (KBr) cm^−1^: 1751 (OAc), 1683 (CO), 1591 (C=N); ^1^H-NMR (CDCl~3~); δ: 2.03, 2.04, 2.06, 2.12 (4s, 12H, 4OAc), 2.23 (s, 3H, CH~3(pyrazole-b)~), 2.54 (s, 3H, CH~3(furan)~), 2.57 (s, 3H, CH~3(pyrazole-a)~), 4.09--4.14 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'b,3\'~ = 3.00 Hz), 4.19--4.24 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'a,3\'~ = 3.00 Hz), 5.14--5.19 (m, 1H, H-3\'), 5.60--5.64 (dd, 1H, H-2\',*J*~1\',2\'~ = 3.00 Hz, *J*~2\',3\'~ = 6.00 Hz), 5.97 (s, 1H, CH~(pyrazole)~), 6.08 (d, 1H, H-1\', *J*~1\',2\'~ = 3.00 Hz), 7.15 (s, 1H, CH~(furan)~); ^13^C-NMR (CDCl~3~); δ: 13.86, 14.47 and 14.58 for (2CH~3(pyrazole)~, CH~3(furan)~), 20.74, 20.80 (2 lines for 4 OCO[CH~3~]{.ul}), 61.65, 65.70, 68.66 and 69.86 for (C-4\', C-3\', C-2\' and C-1\'), 110.97, 113.77, 116.00, 144.72, 145.84, 151.87, 162.89 for (pyrazole and furan carbons), 169.50 ([C]{.ul}O-N), 169.70, 169.80, 169.95, 170.60 (4 O[CO]{.ul}CH~3~); MS: *m/z* (%), 494 (4.19, M^+^+2), 493 (7.52, M^+^+1), 492 (18.80, M^+^), 433 (9.49), 432 (10.73), 397 (13.56), 396 (27.19), 373 (11.47), 372 (9.25), 336 (27.99), 330 (11.96), 275 (10.91), 235 (16.40), 234 (60.30), 233 (86.68), 203 (33.48), 193 (19.36), 192 (30.83), 180 (09.00), 179 (10.11), 175 (12.08), 151 (10.97), 150 (09.25), 138 (19.79), 137 (75.71), 136 (09.49), 123 (09.12), 122 (10.42), 121 (13.69), 115 (23.06), 110 (19.30), 109 (17.02), 103 (09.99), 98 (10.60), 97 (100.00), 96 (17.32), 95 (25.77), 83 (10.42), 81 (16.83), 80 (10.79), 79 (15.84), 73 (11.59), 71 (11.41), 69 (16.71), 67 (10.23), 61 (10.48), 57 (19.17), 55 (22.32), 54 (09.80), 53 (11.47), 51 (10.30); Anal. Calcd for C~23~H~28~N~2~O~10~: C, 56.09; H, 5.73; N, 5.69%; found: C, 56.00; H, 5.62; N, 5.77%.

1-(5-(1\',2\',3\',4\'-Tetrahydroxybutyl)-2-methylfuran-3-carbo-3-yl)-4-phenyl thiosemicarbazide (**20**) \[[@B24-molecules-19-05163]\]. A mixture of 5-(1\',2\',3\',4\'-tetrahydroxybutyl)-2-methylfuran-3-carbohydrazide **1** (3.846 mmoL) and phenyl isothiocyanate (3.846 mmoL) are heated under reflux in ethanol (10 mL) for 2 h. After cooling the thiosemicarbazide that separated was filtered off, washed with little ethanol, and dried. Yield (100%); recrystallized from ethanol as white crystals; mp 133--134 °C; Rf: 0.35 (chloroform--methanol; 5:1; *v/v*); IR(KBr) cm^−1^: 3415--3264 (OH, 3NH), 1659 (CO); ^1^H-NMR (DMSO-*d*~6~); δ: 2.47 (s, 1H, CH~3~-furan with DMSO), 3.34--3.41 (m, 1H, H-4\'b), 3.45--3.48 (m, 1H, H-4\'a), 3.50--3.57 (m, 2H, H-3\', H-2\'), 4.34 (t, 1H, 4\'-OH, *J*~4\',OH~ = 6.15 Hz, D~2~O-exchangeable), 4.42 (d, 1H, 3\'-OH, *J*~3\',OH~ = 6.85 Hz, D~2~O-exchangeable), 4.59 (d, 1H, 2\'-OH, *J*~2\',OH~ = 6.15 Hz, D~2~O-exchangeable), 4.73 (d, 1H, H-1\', *J*~1\',2\'~ = 7.65 Hz), 5.12 (d, 1H, 1\'-OH, *J*~1\',OH~ = 8.40 Hz, D~2~O-exchangeable), 6.72 (s, 1H, CH ~(furan)~), 7.11 (t, 1H, Ar-H~(f)~, *J* = 8.40 Hz), 7.28 (t, 2H, Ar-H~(e)~, *J* = 9.15 Hz), 7.42 (bs, 2H, Ar-H~(d)~), 9.54 (s, 1H, NH~(c)~, D~2~O exchangeable), 9.72 (s, 1H, NH~(b)~, D~2~O exchangeable), 9.97 (s, 1H, NH~(a)~, D~2~O exchangeable); Anal. Calcd for C~17~H~21~N~3~O~6~S: C, 51.64; H, 5.35; N, 10.63%; found: C, 51.70; H, 5.20; N, 10.60%.

*1\'-(5-Methyl-4-(5-(phenylamino)-1,3,4-oxadiazol-2-yl)furan-2-yl)butane-1\',2\',3\',4\'-tetraol* (**21**). To a suspension of thiosemicarbazide **20** (5.063 mmol) in ethanol (50 mL), sodium hydroxide solution (4 N, 5 mL) was added with shaking. A solution of iodine and potassium iodide was added dropwise with stirring till the color of iodine persisted. The precipitate **21** was filtered off, washed with sodium thiosulphate solution, then with water, and dried. Yield (95%); recrystallized from ethanol as white crystals; mp 223--224 °C; Rf: 0.71 (chloroform--methanol; 4:1; *v/v*); IR(KBr) cm^−1^: 3421--3318 (OH), 3242 (NH), 1673 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.54 (s, 3H, CH~3(furan)~), 3.41--3.55 (m, 4H, H-4\'b, H-3\', H-2\', H-4\'a,), 4.37 (t, 1H, 4\'-OH, *J*~4\',OH~ = 6.00 Hz, D~2~O-exchangeable), 4.62 (d, 1H, 3\'-OH, *J*~3\',OH~ = 9.00 Hz, D~2~O-exchangeable), 4.65 (d, 1H, 2\'-OH, *J*~2\',OH~ = 3.00 Hz, D~2~O-exchangeable), 4.77 (d, 1H, H-1\', *J*~1\',2\'~ = 6.00 Hz), 5.19 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.00 Hz, D~2~O-exchangeable), 6.53 (s, 1H, CH~(furan)~), 6.96 (t, 1H, Ar-H~(c)~, *J* = 9.00 Hz), 7.32 (t, 2H, Ar-H~(b)~, *J* = 9.00 Hz), 7.55 (d, 2H, Ar-H~(a)~, *J* = 9.00 Hz), 10.50 (s, 1H, NH, D~2~O-exchangeable); MS: *m/z* (%), 361 (14.29, M^+^), 360 (27.07), 359 (18.30), 312 (19.05), 287 (17.04), 283 (26.32), 247 (19.80), 241 (17.04), 229 (177.79), 221 (23.06), 204 (18.55), 181 (17.04), 173 (20.30), 172 (17.54), 167 (17.54), 152 (20.55), 148 (16.54), 141 (21.05), 137 (15.54), 135 (24.56), 120 (21.80), 117 (18.30), 111 (27.57), 110 (19.05), 109 (20.30), 103 (19.80), 99 (21.55), 98 (26.57), 97 (35.84), 96 (31.08), 95 (30.58), 93 (25.56), 85 (34.59), 84 (29.07), 83 (51.13), 82 (24.31), 81 (37.59), 80 (39.60), 77 (26.32), 76 (18.55), 75 (17.79), 73 (29.82), 71 (49.62), 70 (32.58), 69 (67.67), 68 (29.57), 67 (38.60), 64 (28.57), 61 (19.05), 60 (39.60), 57 (100.00), 56 (27.57), 55 (93.98), 54 (30.58), 53 (26.32), 52 (19.80), 51 (23.06); Anal. Calcd for C~17~H~19~N~3~O~6~: C, 56.51; H, 5.30; N, 11.63%; found: C, 56.47; H, 5.41; N, 11.70%.

*1\'-\[5-Methyl-4-(5-(phenylamino)-1,3,4-oxadiazol-2-yl)furan-2-yl\]butane-1\',2\',3\',4\'-tetrayl tetraacetate* (**22**). A solution of compound **21** (1.108 mmoL) in dry pyridine (10 mL) was treated with acetic anhydride (10 mL) and the mixture was kept overnight with occasional shaking at room temperature. Then it was poured onto crushed ice, and the acetyl derivative **22** that separated out was filtered off, washed with water and dried. Yield (85%); recrystallized from ethanol as white crystals; mp 180--181 °C; Rf: 0.5 (*n*-hexane--ethyl acetate; 2:1; *v/v*); IR(KBr) cm^−1^: 3136 (NH), 1747 (OAc), 1622 (C=N); ^1^H-NMR (CDCl~3~); δ: 2.04, 2.06, 2.08, 2.09 (4s, 12H, 4OAc), 2.60 (s, 3H, CH~3(furan)~), 4.09--4.15 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'b,3\'~ = 6.00 Hz), 4.22--4.27 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'a,3\'~ = 3.00 Hz), 5.16--5.21 (m, 1H, H-3\'), 5.59--5.63 (dd, 1H, H-2\', *J*~1\',2\'~ = 3.00 Hz, *J*~2\',3\'~ = 6.00 Hz), 6.06 (d, 1H, H-1\', *J*~1\',2\'~ = 3.00 Hz), 6.69 (s, 1H, CH~(furan)~), 7.07 (t, 1H, Ar-H~(i)~*, J* = 9.00 Hz), 7.35 (t, 2H, Ar-H~(h)~, *J* = 9.00 Hz), 7.48 (d, 2H, Ar-H~(g)~, *J* = 9.00 Hz), 8.01 (bs, 1H, NH, D~2~O-exchangeable); ^13^C-NMR (CDCl~3~); δ: 13.72 (CH~3(furan)~), 20.72, 20.78, 20.84 (3 lines for 4 CO[CH~3~]{.ul}), 61.65 (C-4\'), 65.86 (C-3\'), 68.61 (C-2\'), 69.79 (C-1\'), 107.45 (j), 108.99 (i), 117.66 (h), 123.17 (g), 129.48 (f), 137.77 (e), 147.91 (d), 154.14 (c), 154.41 (b), 159.51 (a), 169.43, 169.74, 169.84, 170.62 (4 [CO]{.ul}CH~3~); MS: *m/z* (%), 531 (11.12, M^+^+2), 530 (6.24, M^+^+1), 529 (19.12, M^+^), 496 (10.05), 476 (8.68), 452 (9.46), 428 (11.12), 388 (8.39), 374 (8.98), 368 (21.56), 367 (34.93), 329 (10.34), 325 (28.88), 312 (11.41), 308 (16.29), 307 (10.73), 297 (8.68), 285 (8.98), 274 (9.17), 271 (17.07), 270 (100.00), 249 (8.68), 232 (8.98), 193 (9.46), 185 (8.98), 181 (8.68), 178 (10.34), 167 (13.37), 129 (8.49), 127 (10.73), 122 (11.90), 120 (12.00), 115 (18.83), 93 (9.46), 92 (18.93), 78 (12.59), 77 (12.49), 66 (9.85), 52 (12.68); Anal. Calcd for C~25~H~27~N~3~O~10~: C, 56.71; H, 5.14; N, 7.94%; found: C, 56.66; H, 5.14; N, 8.01%.

*5-(5-(1\',2\',3\',4\'-Tetrahydroxybutyl)-2-methylfuran-3-yl)-4-phenyl-2H-1,2,4-triazole-3(4H)-thione* (**23**). In a round bottom flask thiosemicarbazide **20** (1.823 mmoL) was refluxed with 10% aqueous sodium hydroxide solution (20 mL) for 5 h. The reaction mixture was filtered, cooled, and neutralized by gradual addition of dilute hydrochloric acid; the white precipitate of **23** was filtered off and dried. It was recrystallized from ethanol as white crystals. Yield 83%; mp 217--218 °C; Rf: 0.4 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3369 (OH, NH), 1624 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.30 (s, 3H, CH~3(furan)~), 3.29--3.33 (m, 1H, H-4\'b), 3.45--3.47 (m, 3H, H-3\', H-2\', H-4\'a), 4.24--4.29 (m, 2H, 4\'-OH, 3\'-OH, D~2~O-exchangeable), 4.45 (bs, 1H, 2\'-OH, D~2~O-exchangeable), 4.55 (d, 1H, H-1\', *J*~1\',2\'~ = 6.00 Hz), 4.91 (d, 1H, 1\'-OH, *J*~1\',OH~ = 6.00 Hz, D~2~O-exchangeable), 5.48 (s, 1H, CH~(furan)~), 7.32 (m, 2H, Ar-H~(c)~), 7.49 (t, 3H, Ar-H~(b,\ a)~, *J* = 3.00 Hz), 13.92 (s, 1H, NH, D~2~O-exchangeable); MS: *m/z* (%), 379 (5.85, M^+^+2), 378 (10.53, M^+^+1), 377 (22.81, M^+^), 360 (12.38), 359 (30.12), 298 (8.77), 287 (26.80), 286 (100.00), 285 (30.60), 284 (10.14), 237 (7.60), 211 (7.41), 199 (9.75), 183 (7.70), 170 (7.60), 162 (7.12), 155 (8.19), 144 (8.67), 138 (7.21), 131 (8.38), 128 (8.48), 127 (8.97), 124 (8.67), 118 (9.45), 116 (7.41), 104 (9.26), 95 (9.65), 92 (7.02), 91 (8.87), 77 (31.38), 66 (8.19), 61 (14.52), 60 (7.50); Anal. Calcd for C~17~H~19~N~3~O~5~S: C, 54.10; H, 5.07; N, 11.13%; found: C, 54.22; H, 5.22; N, 11.00%.

*5-(5-(1\',2\',3\',4\'-Tetraacetoxybutyl)-2-methylfuran-3-yl)-4-phenyl-2-N-acetyl-1,2,4-triazole-3-(4H)-thione* (**24**). A solution of compound **23** (1.061 mmoL) in dry pyridine (15 mL) was treated with acetic anhydride (15 mL) and the mixture was kept overnight with occasional shaking at room temperature. Then it was poured onto crushed ice, and the acetyl derivative **24** that separated out was filtered off, washed with water and dried. Yield 97%; recrystallized from ethanol as pale yellow needles; mp 168--169 °C; Rf: 0.49 (*n*-hexane--ethyl acetate; 2:1; *v/v*); IR (KBr) cm^−1^: 1747 (OAc, N-Ac), 1622 (C=N); ^1^H-NMR (CDCl~3~); δ: 1.97, 1.99, 2.01 (3s, 12H, 4OAc), 2.50 (s, 3H, CH~3(furan)~), 2.77 (s, 3H, N-Ac), 3.98--4.04 (dd, 1H, H-4\'b, *J*~4\'a,4\'b~ = 12.00 Hz, *J*~4\'b,3\'~ = 6.00 Hz), 4.10--4.16 (dd, 1H, H-4\'a, *J*~4\'a,4\'b~ = 15.00 Hz, *J*~4\'a,3\'~ = 3.00 Hz), 5.03--5.07 (m, 1H, H-3\'), 5.39--5.46 (m, 1H, H-2\'), 5.48 (s, 1H, CH~(furan)~), 5.79 (d, 1H, H-1\', *J*~1\',2\'~ = 3.00 Hz), 7.20--7.30 (m, 2H, Ar-H~(c)~), 7.53 (t, 3H, Ar-H~(b,\ a)~, *J* = 3.00 Hz); MS: *m/z* (%), 589 (1.52 , M^+^+2), 588 (3.93 , M^+^+1), 587 (10.34, M^+^), 547 (9.46), 546 (26.15), 545 (79.56), 485 (6.60), 384 (20.24), 383 (57.91), 382 (5.92), 370 (4.92), 342 (12.32), 341 (28.54), 329 (4.49), 328 (15.48), 324 (11.95), 323 (13.76), 299 (8.53), 298 (6.72), 288 (7.01), 287 (21.33), 286 (100.00), 285 (9.11), 284 (5.98), 270 (4.66), 256 (6.60), 115 (10.38), 77 (8.82), 60 (4.34), 51 (2.25); Anal. Calcd for C~27~H~29~N~3~O~10~S: C, 55.19; H, 4.97; N, 7.15%; found: C, 55.11; H, 4.99; N, 7.00%.

*5-(5-(Tetrahydro-2\',3\'-dihydroxyfuran-1\'-yl)-2-methylfuran-3-yl)-4-phenyl-2H-1,2,4-triazole-3-(4H)-thione* (**25**). A solution of compound **23** (1.823 mmoL) was heated with aqueous acetic acid (150 mL, 10%) under reflux for 5 h. After cooling the product **25** that separated out was filtered off, washed with water and dried. Yield 80%; recrystallized from ethanol as off-white needles; mp 217--218 °C; Rf: 0.4 (chloroform--methanol; 5:1; *v/v*); IR (KBr) cm^−1^: 3407--3184 (OH, NH), 1625 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.32 (s, 3H, CH~3(furan)~), 3.47--3.51 (dd, 1H, H-4\'b, *J*~3\',4\'b~ = 3.00 Hz, *J*~4\'b,4\'a~ = 9.00 Hz), 3.85--3.90 (dd, 2H, H-3\', H-4\'a, *J*~3\',4\'a~ = 6.00 Hz, *J*~4\'b,4\'a~ = 9.00 Hz), 3.97(bs, 1H, H-2\'), 4.24 (d, 1H, H-1\', *J*~1\',2\'~ = 9.00 Hz), 4.86 (d, 1H, 3\'-OH, *J*~3\',OH~ = 3.00 Hz, D~2~O-exchangeable), 4.92 (d, 1H, 2\'-OH, *J*~2\',OH~ = 6.00 Hz, D~2~O-exchangeable), 5.53 (s, 1H, CH~(furan)~), 7.32--7.35 (m, 2H, Ar-H~(c)~), 7.49 (t, 3H, Ar-H~(b,\ a)~, *J* = 3.00 Hz), 13.96 (bs, 1H, NH, D~2~O-exchangeable); MS: *m/z* (%), 360 (23.69, M^+^+1), 359 (20.21, M^+^), 357 (20.21), 341 (20.21, M^+^-H~2~O), 326 (20.21, M^+^-SH), 321 (26.48), 316 (24.74), 314 (24.74), 305 (24.39), 289 (29.97), 255 (20.91, M^+^-C~4~H~8~O~3~), 225 (26.48), 212 (25.44), 203 (25.78), 167 (25.78), 153 (27.53), 149 (32.06), 141 (27.53), 139 (24.74), 129 (25.78), 118 (24.74), 112 (25.44), 111 (25.44), 97 (30.31), 95 (29.27), 94 (50.52), 93 (27.53), 90 (25.78), 83 (43.21), 81 (33.80), 74 (29.97), 73 (30.31), 71 (56.10), 70 (33.80), 69 (49.48), 67 (24.74), 61 (24.74), 60 (45.99), 57 (100.00), 56 (42.16), 55 (76.66), 54 (24.39), 52 (25.78); Anal. Calcd for C~17~H~17~N~3~O~4~S: C, 56.81; H, 4.77; N, 11.69%; found: C, 56.77; H, 4.77; N, 11.74%.

*4-(4,5-Dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-5-methylfuran-2-carbaldehyde* (**26**). A solution of compound **23** (2.122 mmol) in distilled water (20 mL) was treated dropwise with a solution of sodium metaperiodate (6.366 mmol) in distilled water (20 mL) with continuous stirring for 5 h, the formyl derivative **26** that separated out was filtered off, washed with water, and dried. Yield 48%; recrystallized from ethanol as pale yellow needles; mp 237--238 °C; Rf: 0.77 (chloroform--methanol; 20:1; *v/v*); IR (KBr) cm^−1^: 3354 (NH), 1681 (CHO), 1600 (C=N); ^1^H-NMR (DMSO-*d*~6~); δ: 2.46 (s, 3H, CH~3(furan)~ with DMSO), 6.65 (d, 1H, CH~(furan)~), 7.39 (t, 2H, Ar-H~(c)~, *J* = 3.00 Hz), 7.50--7.57 (m, 3H, Ar-H~(b,\ a)~), 9.32 (s, 1H, CHO), 14.17 (s, 1H, NH, D~2~O exchangeable); MS: *m/z* (%), 287 (6.12, M^+^+2), 286 (19.64, M^+^+1), 285 (100.00, M^+^), 284 (33.49), 256 (19.21), 228 (17.85), 212 (6.13), 169 (9.29), 150 (7.92), 149 (16.37), 135 (6.34), 134 (13.27), 118 (6.39), 109 (7.29), 106 (6.53), 93 (6.00), 91 (11.22), 80 (68.01), 79 (9.20), 78 (13.83), 77 (61.00), 76 (7.14), 69 (6.12), 66 (7.25), 65 (13.54), 64 (43.58), 63 (10.89), 55 (5.63), 53 (6.78), 52 (14.86), 51 (47.93), 50 (13.88); Anal. Calcd for C~14~H~11~N~3~O~2~S: C, 58.93; H, 3.89; N, 14.73%; found: C, 58.90; H, 4.00; N, 14.88%.

3.3. Antioxidant and Anticancer Screening
-----------------------------------------

### 3.3.1. Materials

Mammalian cell lines: MCF-7 cells (human breast cancer cell line were obtained from VACSERA Tissue Culture Unit (Cairo, Egypt). Chemicals used: Dimethyl sulfoxide (DMSO), crystal violet and trypan blue dye were purchased from Sigma (St. Louis, MO, USA). Fetal bovine serum, Dulbecco's Modefied Eagle's Medium (DMEM), RPMI-1640, HEPES buffer solution, L-glutamine, gentamycin and 0.25% trypsin-EDAT were purchased from Lonza (St. Louis, MO, USA). Crystal violet (1%) was made from 0.5% (w/v) crystal violet and 50% methanol, then made up to volume with dd H~2~O and filtered through a Whatman No. 1 filter paper.

### 3.3.2. Cell Line Propagation

The cells were propagated in (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 1% [l]{.smallcaps}-glutamine, HEPES buffer and 50 µg/mL gentamycin. All cells were mentained at 37 °C in humidified atmosphere with 5% CO~2~ and were subcultured two times a week. Cell toxicity was monitored by determining the effect of the examined compound on cell morphology and cell viability.

### 3.3.3. Cytotoxicity Evaluation Using Viability Assay

For the cytotoxicity assays, cells were seeded in 96-well plate at a cell concentration of 1 × 10^4^ cell per well in 100 μL of growth medium. Fresh medium containing different concentrations of the test sample was added after 24 h of seeding. The microtiter plates were incubated at 37 °C in a humidified incubator with 5% CO~2~ for a period of 48 h. Three wells were used for each concentration of the tested sample. Control cells were incubated without test sample and with or without DMSO. After incubation of the cells for 24 h at 37 °C, various concentrations of the sample (50.000, 25.000, 12.500, 6.250, 3.125 and 1.560 μg) were added each separately. The incubation was continued for 48 h and viable cells yield was determined colorimetrically using 3,4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTTB). The water insoluble tetrazolium salt is converted to purple formazan by the mitochondrial dehydrogenase of viable cells. After the end of incubation period, media were aspirated and crystal violet solution (1%) was added to each well for at least 30 min. The stain was removed and plates were rinsed using tap water until all excess stain is removed. Glacial acetic acid (30%) was then added to all wells and mixed thoroughly, then the absorbance of the plates were measured after gently shaken on Microplate Reader (Tecan, Inc., city, country), at 490 nm. All results were corrected for background absorbance detected in wells without added stain. Treated sample was compared with the cell control in the absence of the tested compound. All experiments were carried out in the triplicate. The cell cytotoxic effect of the tested compound was calculated \[[@B27-molecules-19-05163],[@B28-molecules-19-05163]\].

4. Conclusions
==============

Some new aromatic *C*-nucleosides have been prepared from carbohydrate precursors. Their physical and chemical properties were studied, and some of the compounds showed potential antioxidant activities. One of these compounds has been screened for its antitumor activity.

We would like to thank chemistry department, Faculty of Science, Alexandria University, Egypt for providing facilities during this research.

*Sample Availability*: Samples of the compounds are available from the authors.

Author contributions are equally in this work.

The authors declare no conflict of interest.
